• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环细胞外囊泡与脂质和胰岛素代谢有关。

Circulating extracellular vesicles are associated with lipid and insulin metabolism.

机构信息

Center for Physical and Mental Health, Mie University Graduate School of Medicine, Tsu, Japan.

Department of Gastroenterology and Hepatology, Mie University Graduate School of Medicine, Tsu, Japan.

出版信息

Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E574-E582. doi: 10.1152/ajpendo.00160.2018. Epub 2018 Jun 26.

DOI:10.1152/ajpendo.00160.2018
PMID:29944389
Abstract

We have reported that hypertrophic adipocytes release extracellular vesicles (EVs) and the number of circulating adipocyte-derived EVs correlated with insulin and homeostasis model assessment-insulin resistance (HOMA-IR) in a pilot study using obese patients. Here, we explored the association between circulating EV level and various metabolic parameters, including obesity and lipid and glucose metabolisms, among 203 subjects (76 men and 127 women; median age, 54 yr) with or without risk factor for metabolic diseases, who received a 75-g oral glucose tolerance test (OGTT). Circulating EV number was significantly higher in men than in women ( P < 0.001). Circulating EV number in individuals with impaired OGTT pattern was significantly higher compared with those with normal OGTT patterns ( P < 0.05). Multiple regression analysis revealed that circulating EV number correlated most strongly and significantly with elevated triglyceride (TG; t = 8.55, P < 0.001). Additionally, circulating EV number correlated significantly with homeostasis model assessment-β-cell function (HOMA-β; t = 2.38, P < 0.05). Receiver operating characteristic curve revealed that the cutoff value of EV numbers in individuals with elevated serum TG levels (≧150 mg/dl) was identified (136,738 EVs/μl of plasma, P < 0.001, sensitivity 0.842, false-positive rate of 0.257). Perilipin and asialoglycoprotein receptor 1 were detected on a part of isolated circulating EVs, indicating EV release from adipocytes and hepatocytes, which were related to lipid and glucose metabolism. Circulating EVs represent a promising metabolic biomarker for lipid and glucose metabolism and have potential for monitoring metabolic status in humans, including individuals without metabolic risk factors.

摘要

我们曾报道过,肥大脂肪细胞会释放细胞外囊泡(EVs),并且在使用肥胖患者的初步研究中,循环脂肪细胞衍生 EV 的数量与胰岛素和稳态模型评估-胰岛素抵抗(HOMA-IR)相关。在这里,我们在 203 名有或没有代谢疾病风险因素的受试者(76 名男性和 127 名女性;中位年龄 54 岁)中探索了循环 EV 水平与各种代谢参数之间的关联,这些受试者接受了 75g 口服葡萄糖耐量试验(OGTT)。男性的循环 EV 数量明显高于女性(P < 0.001)。糖耐量异常个体的循环 EV 数量明显高于糖耐量正常个体(P < 0.05)。多元回归分析显示,循环 EV 数量与升高的甘油三酯(TG)相关性最强且最显著(t = 8.55,P < 0.001)。此外,循环 EV 数量与稳态模型评估-β细胞功能(HOMA-β)显著相关(t = 2.38,P < 0.05)。ROC 曲线显示,在 TG 水平升高(≧150mg/dl)的个体中,EV 数量的截断值被确定(136738EVs/μl 血浆,P < 0.001,敏感性 0.842,假阳性率 0.257)。在部分分离的循环 EV 上检测到 perilipin 和去唾液酸糖蛋白受体 1,表明 EV 是从脂肪细胞和肝细胞中释放的,这与脂质和葡萄糖代谢有关。循环 EV 是脂质和葡萄糖代谢的有前途的代谢生物标志物,并且有可能监测包括无代谢风险因素的个体在内的人类的代谢状态。

相似文献

1
Circulating extracellular vesicles are associated with lipid and insulin metabolism.循环细胞外囊泡与脂质和胰岛素代谢有关。
Am J Physiol Endocrinol Metab. 2018 Oct 1;315(4):E574-E582. doi: 10.1152/ajpendo.00160.2018. Epub 2018 Jun 26.
2
Circulating adipocyte-derived extracellular vesicles are novel markers of metabolic stress.循环脂肪细胞衍生的细胞外囊泡是代谢应激的新型标志物。
J Mol Med (Berl). 2016 Nov;94(11):1241-1253. doi: 10.1007/s00109-016-1446-8. Epub 2016 Jul 9.
3
Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity.循环细胞外囊泡与病理生理状况相关,包括代谢综合征相关的代谢紊乱,存在于肥胖青少年儿童中。
J Mol Med (Berl). 2024 Jan;102(1):23-38. doi: 10.1007/s00109-023-02386-5. Epub 2023 Oct 24.
4
Vesicles Shed by Pathological Murine Adipocytes Spread Pathology: Characterization and Functional Role of Insulin Resistant/Hypertrophied Adiposomes.病态肥胖细胞分泌的囊泡传播病理学:胰岛素抵抗/肥大脂肪小体的特征和功能作用。
Int J Mol Sci. 2020 Mar 24;21(6):2252. doi: 10.3390/ijms21062252.
5
Increased secretion of adipocyte-derived extracellular vesicles is associated with adipose tissue inflammation and the mobilization of excess lipid in human obesity.脂肪细胞衍生的细胞外囊泡的分泌增加与人类肥胖症中脂肪组织的炎症和多余脂质的动员有关。
J Transl Med. 2024 Jul 4;22(1):623. doi: 10.1186/s12967-024-05249-w.
6
Comparative and functional analysis of plasma membrane-derived extracellular vesicles from obese vs. nonobese women.肥胖女性与非肥胖女性血浆膜衍生细胞外囊泡的比较和功能分析。
Clin Nutr. 2020 Apr;39(4):1067-1076. doi: 10.1016/j.clnu.2019.04.008. Epub 2019 Apr 17.
7
Metabolic characteristics of glucose intolerance: the critical role of obesity.葡萄糖不耐受的代谢特征:肥胖的关键作用。
Exp Clin Endocrinol Diabetes. 2008 Feb;116(2):86-93. doi: 10.1055/s-2007-985382. Epub 2007 Oct 31.
8
Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.血清视黄醇结合蛋白 4 水平与肥胖患者的性别相关,而与胰岛素抵抗无关。
Arch Physiol Biochem. 2010 May;116(2):57-62. doi: 10.3109/13813451003631421.
9
Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.餐后 1 小时血糖升高可识别出血糖正常但β细胞功能受损、胰岛素抵抗和心血管风险状况更差的人群:GENFIEV 研究。
J Clin Endocrinol Metab. 2013 May;98(5):2100-5. doi: 10.1210/jc.2012-3971. Epub 2013 Mar 28.
10
Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.糖耐量正常和1小时血糖过高受试者的代谢特征。
Clin Endocrinol (Oxf). 2008 Oct;69(4):575-9. doi: 10.1111/j.1365-2265.2008.03209.x. Epub 2008 Jan 31.

引用本文的文献

1
Detection and Isolation of Tissue-Specific Extracellular Vesicles From the Blood.从血液中检测和分离组织特异性细胞外囊泡
J Extracell Biol. 2025 Jun 22;4(6):e70059. doi: 10.1002/jex2.70059. eCollection 2025 Jun.
2
Potential effects of lipid lowering and antioxidant activity of exosomes from Phascolosoma esculenta: and studies.可口革囊星虫外泌体的降脂及抗氧化活性的潜在影响: 及 研究。
Front Pharmacol. 2025 Mar 25;16:1560462. doi: 10.3389/fphar.2025.1560462. eCollection 2025.
3
Cell-cell communication: new insights and clinical implications.
细胞间通讯:新的见解和临床意义。
Signal Transduct Target Ther. 2024 Aug 7;9(1):196. doi: 10.1038/s41392-024-01888-z.
4
The association between the size of adipocyte-derived extracellular vesicles and fasting serum triglyceride-glucose index as proxy measures of adipose tissue insulin resistance in a rat model of early-stage obesity.在早期肥胖大鼠模型中,脂肪细胞衍生的细胞外囊泡大小与空腹血清甘油三酯-葡萄糖指数之间的关联,作为脂肪组织胰岛素抵抗的替代指标。
Front Nutr. 2024 Jul 1;11:1387521. doi: 10.3389/fnut.2024.1387521. eCollection 2024.
5
Cell Type-Specific Extracellular Vesicles and Their Impact on Health and Disease.细胞类型特异性细胞外囊泡及其对健康和疾病的影响。
Int J Mol Sci. 2024 Feb 27;25(5):2730. doi: 10.3390/ijms25052730.
6
Adipose Tissue-Derived Extracellular Vesicles: A Promising Biomarker and Therapeutic Strategy for Metabolic Disorders.脂肪组织衍生的细胞外囊泡:代谢紊乱的一种有前景的生物标志物和治疗策略。
Stem Cells Int. 2023 Dec 26;2023:9517826. doi: 10.1155/2023/9517826. eCollection 2023.
7
Circulating extracellular vesicles are associated with pathophysiological condition including metabolic syndrome-related dysmetabolism in children and adolescents with obesity.循环细胞外囊泡与病理生理状况相关,包括代谢综合征相关的代谢紊乱,存在于肥胖青少年儿童中。
J Mol Med (Berl). 2024 Jan;102(1):23-38. doi: 10.1007/s00109-023-02386-5. Epub 2023 Oct 24.
8
Diagnosis of Extracellular Vesicles in Cardiovascular and Metabolic Diseases.心血管代谢疾病中外泌体的诊断。
Adv Exp Med Biol. 2023;1418:171-185. doi: 10.1007/978-981-99-1443-2_12.
9
Distinct microRNA and protein profiles of extracellular vesicles secreted from myotubes from morbidly obese donors with type 2 diabetes in response to electrical pulse stimulation.2型糖尿病病态肥胖供体的肌管在电脉冲刺激下分泌的细胞外囊泡的独特微小RNA和蛋白质谱。
Front Physiol. 2023 Mar 30;14:1143966. doi: 10.3389/fphys.2023.1143966. eCollection 2023.
10
Extracellular Vesicles as Carriers of Adipokines and Their Role in Obesity.细胞外囊泡作为脂肪因子的载体及其在肥胖中的作用
Biomedicines. 2023 Feb 1;11(2):422. doi: 10.3390/biomedicines11020422.